There are errors in Figs [1](#pone.0196885.g001){ref-type="fig"} and [3](#pone.0196885.g002){ref-type="fig"}. The authors have provided corrected versions here.

![Greater beneficial effect of combination treatment with aliskiren and paricalcitol on renal fibrosis in the obstructed kidney.\
(A) Representative renal sections stained with Masson-trichrome (original magnifications, x200). (B) Quantitative analysis of the results for fibrotic area in the renal tubulointerstitium. \*P\<0.001 versus UUO; \*\*P = 0.001 versus UUO; ^\#^P\<0.001 versus UUO+A or UUO+P.](pone.0196885.g001){#pone.0196885.g001}

![Synergistic effect of combination treatment with aliskiren and paricalcitol on the expression of myofibroblasts in the obstructed kidney.\
(A) Representative renal sections stained with α-SMA(original magnification, x200). (B) Quantitative analysis of the results for α-SMA in the renal tubulointerstitium. \*P\<0.001 versus UUO; \*\*P = 0.001 versus UUO; ^\#^P = 0.001 versus UUO+A and P\<0.001 versus UUO+P. α-SMA, α-smooth muscle actin.](pone.0196885.g002){#pone.0196885.g002}
